Iovance Biotherapeutics Inc (IOVA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
4,982,686,000
EV to revenue ratio (TTM)
14
EV to ebitda
-8.68
Financial Performance
Revenue (TTM)
324,969,000
Gross profit (TTM)
157,287,000
EBITDA
-259,603,008
Profitability
Operating margin (TTM)
-52.30%
Profit margin
-89.10%
Return on assets (TTM)
-20.30%
Return on equity (TTM)
-40.40%
Per Share Metrics
Revenue per share (TTM)
0.79
EPS
-0.69
Diluted EPS (TTM)
-0.69
Book value
1.63
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
0
Price to sales ratio (TTM)
15.33
Price to book ratio (TTM)
6.38
Growth
Quarterly earnings growth (YoY)
65.70%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
5
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.833